Radiologist Mobin Master consults with patients seeking to have their filler dissolved – and believes the available figures under represent the problems.
“I think it’s under-reported, if anything,” Dr Master said.
“So we can’t give data to patients. It’s very difficult to give them hard figures as to, ‘This is the percentage risk of a vascular occlusion, this is the percentage risk of blindness in this country,’ for example.”
When 7.30 visited Dr Master’s clinic, he was treating patient Lisa Grove. She had travelled from the US to Melbourne to have her filler dissolved after a “catastrophic” injection below her eyes almost one year ago.
Ms Grove started getting cosmetic injections after cancer reconstruction surgery left her face uneven.
“While I was still in [the nurse’s] chair … my face exploded out in all directions,” Ms Grove said.
Read the full article here.
Dr Master discusses filler with Author Alice Hart-Davis and the effects of longevity.
Read the full article here.
Hyaluronic Acid filler longevity and localisation – MRI evidence. Dr Master’s article has become a trending and highly cited article from 2021. An infographic has been created by Impact Science with PRS USA.
Read the full article here.
Dr Master is presenting at the Annual Royal Australasian College of Radiology Conference on Oct 28 2022.
Dr. Gavin Chan discusses with Dr. Mobin Master, the reasons the overfilled keep asking for more filler, and why doctors keep filling them.
Dr Master will be presenting a Plenary Presentation @ NSS 2022 June 3-5 at Gold Coast Convention Centre
Dr Mobin Master publishes land-mark study – Novel Treatment of Inadvertent Injection of Postseptal Hyaluronic Acid Filler
A novel image-guided treatment of postseptal intraorbital complications of dermal filler injection may help to avoid oculoplastic surgery. This article describes three patients who had postseptal hyaluronic acid confirmed by magnetic resonance imaging. All three patients underwent hyaluronidase treatment using a “magnetic resonance imaging road map” and ultrasound-guided dissolution.
This article demonstrates a novel approach using magnetic resonance imaging to identify and treat inadvertent postseptal complications of hyaluronic acid tear trough treatment in three patients. A 25-gauge needle was inserted in the postseptal component under ultrasound guidance with 80 to 100 units of hyaluronidase (Hylase; Sanofi, Paris, France).
The intralesional ultrasound-guided injection of 80 to 100 IU of hyaluronidase (ultrasound-guided injection) was performed with an ultrasound scanner (Precision Pure; Toshiba, Minato-ku, Tokyo, Japan) and an 18-Mhz, high-frequency probe. All magnetic resonance imaging scans and ultrasound-guided procedures were interpreted and performed by one dual-trained aesthetic physician and radiologist with more than 16 years of specialist experience.
In case 1, a 30-year-old woman had tear trough treatment with 0.25 ml/side of Restylane Volyme (Galderma, Switzerland) hyaluronic acid (technique unknown). Two months later, an additional 0.25 ml of Restylane Volyme was blended on each side (technique unknown). The right tear trough had a poor outcome, with lumpiness and significant malar edema directly after the procedure. Numerous hyaluronidase injections were performed, with up to 1500 IU of hyaluronidase per session in the right tear trough area clinically over a 12-month period, with no clinical resolution. Magnetic resonance imaging was performed, showing postseptal hyaluronic acid (Fig. 1). Ultrasound-guided injection of hyaluronidase was performed. Repeated magnetic resonance imaging demonstrated almost complete dissolution of the postseptal hyaluronic acid (Fig. 2). This patient then underwent surgery, as the medial sub–orbicularis oculi fat approaching the inner canthus was resistant to hyaluronidase treatment.
Dr. Gavin Chan speaks with Dr. Mobin Master, Mr. Bryan Mendelson, and Dr. Ben Burt on tear-troughs.
Dr Master speaks with Dr Gavin Chan about his MRI research in this viral video.
Dr Master is presenting his research with other top experts at the largest aesthetic conference in Australia, on the Gold Coast, Nov 19-21:
Dr Mobin Master (Specialist Radiologist) – ‘The emerging speciality of aesthetic radiology’
Episode 93 hosts Dr Mobin Master, a Specialist Radiologist based in Melbourne, Australia. Mobin is also a cosmetic injector and his unique skill set has allowed him to become a leader in the new field of ‘aesthetic radiology’.
Diagnostic imaging tools including ultrasound be used to help guide safer injecting techniques whereas MRI scans are used to map pre-existing fillers.
We learn how Mobin got into aesthetic radiology, what the most common uses of aesthetic imaging are and look into its future.
OVERFILLED FACES: DIAGNOSIS & TREATMENT WEBINAR
The increasing use of fillers over the past 20 years have led to a plethora of complications- one of which is overfilled faces.
The objective of this meeting is to understand best practices for prevention, clinical assessment, and management of this problem.
We have assembled a multidisciplinary group of clinical experts from around the world to discuss their practices in the diagnosis and management of overfilled faces.
SATURDAY, APRIL 17TH 2021
8AM PST – 12PM PST
(11AM EST – 3PM EST)
SUNDAY, APRIL 18TH 2021
MELBOURNE AUSTRALIA TIME
1AM – 5AM
Dr Mobin Master publishes land-mark study on how long filler lasts and how to localise it in the most prestigious journal “Plastic and Reconstructive Surgery of America” (PRS)
“I’m excited to let all of you know that my most recent addition to the literature has been published in the medical journal Plastic and Reconstructive Surgery. I think you’ll find my article, Hyaluronic acid filler longevity and localization – MRI evidence, quite interesting.
I’ve included the abstract below to give you a good idea of the topic:
Hyaluronic Acid (HA) is the most commonly used facial dermal filler in aesthetic medicine. Identification of placement, longevity and localization of HA fillers are becoming increasingly important. This article proposes a practical approach to monitoring the location and longevity of HA, using Magnetic Resonance Imaging (MRI).
